with innovative medical devices, ground-breaking life science research, new diagnostic tools, and new therapeutics. We’re venture capitalists with an edge: years of hands-on management experience combined with extensive technical expertise, and a track record of finding, funding and developing great ideas and great companies.
"As a CEO, I value both BioVentures Investors' experience in building shareholder value and their background as founders and advisors to emerging companies."
Peter Vitulli
President & CEO
Sciona
"BioVentures Investors brings a wealth of operating experience and scientific knowledge."
Stella M. Sung, Ph.D.
Chief Business Officer
Cylene Pharmaceuticals
"I'd call BioVentures Investors a 'user-friendly' venture capital firm. They understand technology development timelines and the issues related to medical devices."
Steven J. Tallarida
President Spirus Medical and ,
Founder AngioLink Corporation.
"What really sets them apart is their maturity, their understanding of the whole world of start-ups and what it takes to get a new idea and technology off the ground."
James Lousararian
President & CEO
Verax Biomedical